Tīmeklis2007. gada 1. apr. · We performed the FAB/LMB96 trial to assess the possibility of reducing treatment in children/adolescents with intermediate-risk B-NHL without … TīmeklisThe aim of our study was to analyze our experience of the treatment with FAB-LMB protocols and analyze the clinical and demographic characteristics of children with …
Rituximab in addition to LMB-based chemotherapy regimen in …
Tīmeklis2009. gada 1. okt. · We examined the role of hematopoietic stem cell transplantation (HSCT) for patients aged≤18 years with refractory or recurrent Burkitt (n=41), lymphoblastic (n=53), diffuse large B cell (DLBCL; n=52), and anaplastic large cell lymphoma (n=36), receiving autologous (n=90) or allogeneic (n=92; 43 matched … Tīmeklis2007. gada 1. apr. · We performed the FAB/LMB96 trial to assess the possibility of reducing treatment in children/adolescents with intermediate-risk B-NHL without … crockery store bowls
Bilateral Renal Infiltration by Burkitt Lymphoma: Case Report
Tīmeklis2012. gada 3. sept. · Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is … Tīmeklis2024. gada 4. jūn. · FAB/LMB96-based protocol, with some minor modifications (Fig. S1 in the Supplementary Ap - pendix).3,4 All the patients received prephase treat - ment … TīmeklisResults of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for … buffers prevent dramatic changes in ph